• Neurocrine Biosciences average ebit margin for 2023 was 10.51%, a 16.65% increase from 2022.
• Neurocrine Biosciences average ebit margin for 2022 was 9.01%, a 33.26% increase from 2021.
• Neurocrine Biosciences average ebit margin for 2021 was 13.5%, a 34.72% decline from 2020.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues